Colgate-Palmolive Co (NYSE:CL) recently announced a dividend of $0.5 per share, payable on 2024-05-15, with the ex-dividend date set for 2024-04-19. As investors look forward to this upcoming ...
Colgate-Palmolive Company (NYSE:CL) will increase its dividend from last year's comparable payment on the 15th of May to $0.50. The payment will take the dividend yield to 2.3%, which is in line ...
Colgate-Palmolive Co (NYSE:CL) recently announced a dividend of $0.5 per share, payable on 2024-05-15, with the ex-dividend date set for 2024-04-19. As investors look forward to this upcoming payment, ...
Colgate-Palmolive's latest dividend increase of 4% and interest rates cut may be a positive sign for CL investors. Its margins are slowly improving, making it a more compelling investment than ...
In the last three months, 9 analysts have published ratings on Colgate-Palmolive CL, offering a diverse range of perspectives from bullish to bearish. The table below provides a snapshot of their ...
Ottenstein said Colgate-Palmolive Company (NYSE:CL) is the firm's top pick into the earnings season due to its forecast that the company is the most ahead of consensus estimates in both sales and EPS.
In the latest market close, Colgate-Palmolive (CL) reached $86.75, with a +0.67% movement compared to the previous day. The stock's performance was ahead of the S&P 500's daily loss of 0.58%.
If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider ...
On Wednesday, Stifel, a financial services company, updated its outlook on Colgate-Palmolive Company (NYSE:CL), increasing the stock price target to $94 from the previous $89 while maintaining a ...
In a report released yesterday, Christopher Carey from Wells Fargo maintained a Hold rating on Colgate-Palmolive (CL – Research Report), with a price target of $90.00. The company’s shares ...
According to GlobalData’s company profile on Colgate-Palmolive, Nanoemulsion cosmetics was a key innovation area identified from patents. Colgate-Palmolive's grant share as of February 2024 was 63%.